← boothcheck

CAI vs LH stock comparison

CARIS LIFE SCIENCES, INC. vs LABCORP HOLDINGS INC., two Medical Diagnostics stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

Where CAI and LH diverge most: on net margin, CAI reads -20.5% and LH reads 6.7%; on return on equity, CAI reads -25.4% and LH reads 10.8%. The rest of the comparable metrics sit closer together. On valuation, today's CAI price has a different growth bar priced in than LH (+33.0% implied for CAI vs +6.9% for LH); the higher figure is the steeper assumption to clear, not a better or worse stock. What LH's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.

CAI vs LH: the numbers

MetricCAILH
Price$15.68$308.95
Market cap$4.4B$25.6B
SectorMedical DiagnosticsMedical Diagnostics
StageGrowthMature
Implied growth (priced in)+33.0%+6.9%
P/E27.4
P/B7.472.93
P/S6.031.81
EV/EBITDA82.519.2
Revenue growth+91.2%+7.4%
Gross margin28.7%
Operating margin2.4%10.8%
Net margin-20.5%6.7%
Return on equity-25.4%10.8%
Return on assets-12.9%4.9%
Return on invested capital2.0%7.5%
FCF yield2.8%5.4%
Dividend yield0.9%
Debt / equity0.640.73
Current ratio7.051.73
Altman Z (solvency)3.153.06
Piotroski F (quality)5 / 94 / 9
Full CAI report → Full LH report →
Get boothcheck's read on CAI and LH, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.